IL17A and metabolic dysfunction-associated steatotic liver disease: Indeed, it has been shown that intestinal Th17 cells and IL-17 slow the progression of NAFLD/NASH, which is associated with the restoration of the intestinal barrier that is dependent on the gut microbiota [187].